Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-60.76%Return on Equity
VS
Market
Sector
Industry
History
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information
Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMED PHARMACEUTICALS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INM - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 13.43M | $ -8.16M | -60.76% |
| 3/31/2025 | $ 7.02M | $ -8.31M | -118.37% |
| 12/31/2024 | $ 6.18M | $ -7.91M | -128.01% |
| 9/30/2024 | $ 8.4M | $ -6.82M | -81.19% |
| 6/30/2024 | $ 9.21M | $ -7.68M | -83.37% |
| 3/31/2024 | $ 11.1M | $ -6.08M | -54.72% |
| 12/31/2023 | $ 12.77M | $ -6.35M | -49.73% |
| 9/30/2023 | $ 9.58M | $ -6.97M | -72.81% |
| 6/30/2023 | $ 12.09M | $ -7.95M | -65.74% |
| 3/31/2023 | $ 12.39M | $ -15.48M | -124.96% |
Key Performance Insights, Last 5 Years
- INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, INMED PHARMACEUTICALS INC's average ROE has been -104.45%.
- The median ROE for INMED PHARMACEUTICALS INC during this period was -96.1%
- INMED PHARMACEUTICALS INC reached its highest ROE over the past 5 years at -49.73%.
- The lowest ROE recorded by INMED PHARMACEUTICALS INC in the same timeframe -204.88%
INMED PHARMACEUTICALS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for INMED PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 4.49M ]
(=) ROE [ 0% ] INM - Return on Equity, Last 5 years
-204.88%
Minimum
Jun 30, 2022
-49.73%
Maximum
Dec 31, 2023
-104.45%
Average
-96.1%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |